CDK6 and hepatocellular carcinoma: To rule out that IGF2BP2 might affect the protein stability of CDK6, we used cycloheximide to block the translation of MDA‐MB‐231 and HCC‐1806 cell lines and assayed the quantity of CDK6 protein in shRNA‐NC and shIGF2BP2‐1.